Model‐Based Assessment of Alternative Study Designs in Pediatric Trials. Part II: Bayesian Approaches

by Smania, G, Baiardi, P, Ceci, A, Cella, M, Magni, P
Published 2016

Model‐Based Assessment of Alternative Study Designs in Pediatric Trials. Part I: Frequentist Approaches

by Smania, G, Baiardi, P, Ceci, A, Magni, P, Cella, M
Published 2016

White Paper: Landscape on Technical and Conceptual Requirements and Competence Framework in Drug/Disease Modeling and Simulation

by Vlasakakis, G, Comets, E, Keunecke, A, Gueorguieva, I, Magni, P, Terranova, N, Della Pasqua, O, de Lange, E C, Kloft, C
Published 2013

A Review of Mixed-Effects Models of Tumor Growth and Effects of Anticancer Drug Treatment Used in Population Analysis

by Ribba, B, Holford, N H, Magni, P, Trocóniz, I, Gueorguieva, I, Girard, P, Sarr, C, Elishmereni, M, Kloft, C, Friberg, L E
Published 2014

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development

by Swat, MJ, Moodie, S, Wimalaratne, SM, Kristensen, NR, Lavielle, M, Mari, A, Magni, P, Smith, MK, Bizzotto, R, Pasotti, L, Mezzalana, E, Comets, E, Sarr, C, Terranova, N, Blaudez, E, Chan, P, Chard, J, Chatel, K, Chenel, M, Edwards, D, Franklin, C, Giorgino, T, Glont, M, Girard, P, Grenon, P, Harling, K, Hooker, AC, Kaye, R, Keizer, R, Kloft, C, Kok, JN, Kokash, N, Laibe, C, Laveille, C, Lestini, G, Mentré, F, Munafo, A, Nordgren, R, Nyberg, HB, Parra-Guillen, ZP, Plan, E, Ribba, B, Smith, G, Trocóniz, IF, Yvon, F, Milligan, PA, Harnisch, L, Karlsson, M, Hermjakob, H, Le Novère, N
Published 2015